|
22 Aug 2011 |
Immune Response BioPharma Reports NeuroVax MS Vaccine Increased Results with Women Taking Estrogen
|
|
18 Aug 2011 |
Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
|
|
15 Aug 2011 |
Inviragen and University of Texas Medical Branch Receive Funding for Development of a Novel Recombinant Chikungunya Virus Vaccine
|
|
12 Aug 2011 |
Advaxis Completes Pre-IND Meeting for ADXS-PSA
|
|
12 Aug 2011 |
TapImmune to Sponsor Phase 1 Breast Cancer Vaccine Trial Following Recent FDA Approval of Investigational New Drug Application
|
|
12 Aug 2011 |
New Tuberculosis Vaccine Enters Phase IIb Proof-of-Concept Trial in People Living with HIV in Senegal and South Africa
|
|
10 Aug 2011 |
Genesis Biopharma Signs Cooperative Research and Development Agreement With the National Cancer Institute to Develop Cancer Immunotherapies
|
|
05 Aug 2011 |
New Hope for Immune Therapy for Children and Young Adults With Type 1 Diabetes: Founder of Orban Biotech's Landmark Findings for Abatacept Published in The Lancet
|
|
03 Aug 2011 |
International Vaccine Institute and Inviragen Announce a Collaboration to Accelerate Development of a Dengue Vaccine
|
|
03 Aug 2011 |
NanoBio Secures Novel Antigen Source for its Intranasal RSV Vaccine
|
|
03 Aug 2011 |
Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV)
|
|
01 Aug 2011 |
AbD Serotec and Merck Sign License Agreement for Use of HuCAL GOLD in Vaccine Research
|
|
26 Jul 2011 |
VaxOnco to Sponsor Phase I Trial of a Folate Receptor Alpha-targeted Breast/Ovarian Cancer Therapeutic Vaccine That Recently Received Investigational New Drug Approval From FDA
|
|
21 Jul 2011 |
Vical Reports Successful Nonclinical Results With Vaxfectin(R) Adjuvant
|
|
21 Jul 2011 |
BioSante Pharmaceuticals Signs Melanoma Vaccine License
|
|
20 Jul 2011 |
Dynavax Phase 3 Demonstrates Superiority and Safety of HEPLISAV(TM) vs. Engerix-B(R)
|
|
20 Jul 2011 |
Aeterna Zentaris Successfully Reached a Key Milestone in the Non-Clinical Development of its Oral Prostate Cancer Vaccine Candidate, AEZS-120
|
|
18 Jul 2011 |
Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS' HIV Vaccine VRX1273
|
|
18 Jul 2011 |
SEEK Announces Clinical Proof of Efficacy in HIV Vaccine Phase Ib/II Human Trial
|
|
18 Jul 2011 |
MEDIMMUNE SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR QUADRIVALENT SEASONAL NASAL SPRAY INFLUENZA VACCINE
|
|
18 Jul 2011 |
Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial
|
|
15 Jul 2011 |
Inovio Pharmaceuticals Demonstrates T Cell Immune Response Durability with Fourth Dose of Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
|
|
14 Jul 2011 |
Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
|
|
14 Jul 2011 |
Vical and Astellas Announce Worldwide License Agreements for TransVax(TM) Cytomegalovirus Vaccine
|
|
14 Jul 2011 |
GlaxoSmithKline and Human Genome Sciences Receive European Authorization for BENLYSTA (Belimumab)
|
